蛋白激酶抑制剂阿尔法通过cAMP-EPAC信号重编程驱动Ewing肉瘤中的温克里斯抗性
Xin Zhou1,2, Yating Yu2, Hao Qiu1
1Department of Orthopedic Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Molecular carcinogenesis
|November 28, 2025
概括
蛋白激酶抑制剂α (PKIA) 通过重新编程cAMP-EPAC信号来驱动尤宁肉瘤中的化学抵抗. 通过EPAC抑制剂向这种途径,可以克服患者的耐药性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症信号传递 癌症信号传递
背景情况:
- 尤文肉瘤 (ES) 是一种具有攻击性的骨癌,对抗性病例的治疗选择有限.
- 在ES中对温克里斯耐药性的机制尚未完全理解.
- 确定新的治疗点对于改善患者的治疗结果至关重要.
研究的目的:
- 为了研究蛋白质激酶抑制剂α (PKIA) 在Ewing肉瘤中的温克里斯耐药性的作用.
- 阐明化学抵抗性ES细胞中PKIA调节的信号通路.
- 评估针对ES的cAMP-EPAC轴的治疗潜力.
主要方法:
- 对抗温克里斯的ES细胞进行转录基因分析.
- 在体外研究评估PKIA表达及其对cAMP信号传递的影响.
- 使用ESI-09.9进行EPAC的药理抑制.
- 在体内异种移植研究中,PKIA被击倒.
主要成果:
- 耐药ES细胞中的PKIA显著上调,并与患者的存活率差相关.
- 过度表达PKIA激活了EPAC-Rap1-ERK通路,促进了药物排放和生存.
- 通过ESI-09抑制EPAC可以逆转温克里斯耐药性.
- 在异种移植中,PKIA knockdown恢复了对温克里斯的敏感性.
结论:
- 通过cAMP-EPAC信号重编程,PKIA是Ewing肉瘤中化学抵抗的关键驱动因素.
- 针对cAMP-EPAC轴是一个有前途的治疗策略,用于克服ES中的温克里斯抗性.
- PKIA表现出取决于背景的作用,在初级ES中充当瘤抑制剂,并在耐药/转移性瘤中促进存活.
相关概念视频
cAMP-dependent Protein Kinase Pathways
8.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K


